WATCH TV LIVE

Tags: Roche | fda | Alzheimers | test

Roche Gets Breakthrough Status for Alzheimer's Test Elecsys

(Dreamstime)

Friday, 20 July 2018 08:24 AM EDT

ZURICH - The U.S. Food and Drug Administration has granted Roche an accelerated review for its Elecsys product used to diagnose Alzheimer's disease, the Swiss drugmaker said Friday.

The FDA gave breakthrough device designation to Elecsys, which examines the cerebrospinal fluid in adult patients with cognitive impairment who are being evaluated for Alzheimer's disease or other causes of dementia.

Click Here to comment on this article

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

Yes, Send Me News Alerts via email

(Optional for Local News)

Privacy: We never share your email address.

Join the Newsmax Community

Read and Post Comments
Please review Community Guidelines before posting a comment.

Find Your Condition

Cancer	Heart Disease
Obesity	Arthritis
Alzheimer's/Dementia	Digestive Problems
Cold/Flu	Depression
Allergies	High Cholesterol
Chronic Pain	Thyroid Disorders
Menopause	Osteoporosis
Autism	Anxiety
High Blood Pressure	Diabetes

More Conditions

TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.